69 related articles for article (PubMed ID: 14689066)
1. The long-term efficacy of imatinib with hepatic resection or other local treatment for gastrointestinal stromal tumours liver metastases: a retrospective cohort study.
Wen H; Huang Y; Huang S; Xiao H; Xie W; Zhou Q; Tan L; Ding Y; Liu X; Yu Y; Song Z; Shen S; Chen Z; Zhang X
Int J Surg; 2024 Apr; 110(4):2151-2161. PubMed ID: 38619177
[TBL] [Abstract][Full Text] [Related]
2. Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era.
Turley RS; Peng PD; Reddy SK; Barbas AS; Geller DA; Marsh JW; Tsung A; Pawlik TM; Clary BM
Cancer; 2012 Jul; 118(14):3571-8. PubMed ID: 22086856
[TBL] [Abstract][Full Text] [Related]
3. Imatinib mesylate: past successes and future challenges in the treatment of gastrointestinal stromal tumors.
Ksienski D
Clin Med Insights Oncol; 2011; 5():365-79. PubMed ID: 22174597
[TBL] [Abstract][Full Text] [Related]
4. Microwave ablation for painful chest wall metastases from gastrointestinal stromal tumor: a case report.
Wang S; Wang L; Li T; Li Y; Zhuang M; Lu M
Front Oncol; 2024; 14():1215479. PubMed ID: 38715791
[TBL] [Abstract][Full Text] [Related]
5. Hemodialysis and imatinib: Plasma levels, efficacy and tolerability in a patient with metastatic GIST - Case report.
De Luca I; Miliziano D; Guerra G; Colombo R; Morosi C; Sposito C; Fiore M; Venturelli E; Sangalli C; Casali PG; Cavalleri A; Fumagalli E
Heliyon; 2024 Apr; 10(7):e28494. PubMed ID: 38596050
[TBL] [Abstract][Full Text] [Related]
6. Criminal or bystander: imatinib and second primary malignancy in GIST patients.
Kanda T
Chin J Cancer Res; 2013 Oct; 25(5):490-2. PubMed ID: 24255570
[No Abstract] [Full Text] [Related]
7. Ultrasound-Guided Intraoperative Radiofrequency Ablation and Surgical Resection for Liver Metastasis from Malignant Gastrointestinal Stromal Tumors.
Yoon IS; Shin JH; Han K; Kim PN; Kim KH; Kang YK; Ko HK
Korean J Radiol; 2018; 19(1):54-62. PubMed ID: 29354000
[TBL] [Abstract][Full Text] [Related]
8. Metastatic liver disease from non-colorectal, non-neuroendocrine, non-sarcoma cancers: a systematic review.
Uggeri F; Ronchi PA; Goffredo P; Garancini M; Degrate L; Nespoli L; Gianotti L; Romano F
World J Surg Oncol; 2015 May; 13():191. PubMed ID: 26022107
[TBL] [Abstract][Full Text] [Related]
9. Liver resection for metastasis due to malignant mesenchymal tumours.
Stavrou GA; Flemming P; Oldhafer KJ
HPB (Oxford); 2006; 8(2):110-3. PubMed ID: 18333257
[TBL] [Abstract][Full Text] [Related]
10. Combined surgical and molecular therapy: the gastrointestinal stromal tumor model.
Gold JS; Dematteo RP
Ann Surg; 2006 Aug; 244(2):176-84. PubMed ID: 16858179
[TBL] [Abstract][Full Text] [Related]
11. Targeting the molecular pathophysiology of gastrointestinal stromal tumors with imatinib. Mechanisms, successes, and challenges to rational drug development.
Demetri GD
Hematol Oncol Clin North Am; 2002 Oct; 16(5):1115-24. PubMed ID: 12512386
[TBL] [Abstract][Full Text] [Related]
12. The clinical characteristics and the role of surgery and imatinib treatment in patients with liver metastases from c-Kit positive gastrointestinal stromal tumors (GIST).
Rutkowski P; Nyckowski P; Grzesiakowska U; Nowecki ZI; Nasierowska-Guttmejer A; Pienkowski A; Dudek K; Krawczyk M; Ruka W
Neoplasma; 2003; 50(6):438-42. PubMed ID: 14689066
[TBL] [Abstract][Full Text] [Related]
13. Surgical treatment of gastrointestinal stromal tumors in the imatinib (STI-571) era.
Wu PC; Langerman A; Ryan CW; Hart J; Swiger S; Posner MC
Surgery; 2003 Oct; 134(4):656-65; discussion 665-6. PubMed ID: 14605627
[TBL] [Abstract][Full Text] [Related]
14. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
[TBL] [Abstract][Full Text] [Related]
15. Role of computed tomography in the follow-up of hepatic and peritoneal metastases of GIST under imatinib mesylate treatment: a prospective study of 54 patients.
Vanel D; Albiter M; Shapeero L; Le Cesne A; Bonvalot S; Le Pechoux C; Terrier P; Petrow P; Caillet H; Dromain C
Eur J Radiol; 2005 Apr; 54(1):118-23. PubMed ID: 15797301
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]